← Back to Search

Control Group - Healthy Subjects for Acid Reflux (PC02 Trial)

N/A
Waitlist Available
Led By Ronnie Fass, MD
Research Sponsored by Southern Arizona VA Health Care System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up na there is no exact timeframe.
Awards & highlights
No Placebo-Only Group

Summary

To determine the effect of intraesophageal high PCO2 solution as compared to acidic and saline solutions on subjects' heartburn sensation using stiumlus-response functions.

Eligible Conditions
  • Acid Reflux

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~na there is no exact timeframe.
This trial's timeline: 3 weeks for screening, Varies for treatment, and na there is no exact timeframe. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The Mechanism of GERD

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Control Group - Healthy SubjectsActive Control1 Intervention
Healthy volunteers with normal EGD.
Group II: NERD GroupActive Control1 Intervention
Subjects with NERD. Heartburn symp x2 wk for 3 months. Normal EGD and abnormal 24 hour pH.

Find a Location

Who is running the clinical trial?

Southern Arizona VA Health Care SystemLead Sponsor
10 Previous Clinical Trials
888 Total Patients Enrolled
Ronnie Fass, MDPrincipal InvestigatorSouthern Arizona Veterans Health Care System
10 Previous Clinical Trials
399 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top